Montelukast
Montelukast (Singulair) is a leukotriene receptor antagonist used for asthma prevention, exercise-related airway narrowing and allergic rhinitis symptoms. This catalogue includes Singulair and Montair tablets.
Key points
- Neuropsychiatric warning: Serious neuropsychiatric events, including agitation, depression, sleep disturbance and suicidal thoughts or behaviour, have been reported with montelukast.
- Acute attacks: Montelukast does not reverse sudden airway narrowing during an acute asthma attack.
- Corticosteroids: Montelukast should not be abruptly substituted for inhaled or oral corticosteroids.
Brands and forms in this catalogue
Singulair is the originator brand associated with Merck, while Montair is listed as a Cipla Ltd product. Both listed Montelukast medicines are tablets, so the catalogue distinguishes brands and listed strengths rather than pharmaceutical forms. Respiratory Health
Further reading
Related articles
29 Jul 2026 ⋅ 8 min read
Allergy in the UAE: Dust, Air Conditioning and What Actually Helps
Allergy here is driven by airborne dust and indoor dust mites rather than a pollen season, so symptoms often run year round. What the triggers are, what the treatment classes do, and why the local pharmacy shelf uses names you may not recognise.
Read guide
29 Jul 2026 ⋅ 8 min read
Hives and Itchy Welts: What Triggers Them and What Settles Them
Hives usually clear within days and can often be treated at home with antihistamines. What triggers them, why heat and sweat set them off for some people, and the swelling that means calling emergency services.
Read guide